In situ localization of lnterleukin-6 in normal skin and atrophic cutaneous disease

International Archives of Allergy and Immunology

Volumn 99, Issue 1, 1992, Pages 44-49

  Romero, Luz I ^a   Pincus, Stephanie H ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Epidermal atrophy; Interleukin 6; Lichen sclerosus; Scleroderma

Indexed keywords

AVIDIN; BIOTIN; CYTOKINE; INTERLEUKIN 6; PEROXIDASE; POLYCLONAL ANTIBODY;

ARTICLE; BALANITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATINOCYTE; LICHEN SCLEROSUS ET ATROPHICUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCLERODERMA; SKIN; SKIN ATROPHY; SKIN BIOPSY; TISSUE DISTRIBUTION;

ANTIBODY SPECIFICITY; ATROPHY; AUTOANTIBODIES; BALANITIS; EPIDERMIS; HUMAN; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; LICHENOID ERUPTIONS; MALE; RADIOIMMUNOASSAY; SCLERODERMA, CIRCUMSCRIBED; SCLERODERMA, SYSTEMIC; SKIN; SKIN DISEASES; SUPPORT, NON-U.S. GOV'T;

EID: 0027054495     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000236334     Document Type: Article

References (28)

1. Muraguchi A, Hirano T, Tang B. Matsuda T, Horii Y, Nakajima K, Kishimoto T: The essential role of B-cell stimulatory factor 2 (BSF-2/ IL-6) for the terminal differentiation of B cells. J Exp Med 1988;167:322-344.
2. Chiu CP, Moulds C, Coffman RL, Rennick D, Lee F: Multiple biological activities arc expressed by mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells. Proc Natl Acad Sci USA 1988;85:7099-7103.
3. Houssiau FA, Coulie PG, Van Snick J: Distinct roles of IL-I and IL-6 in T cell activation. J Immunol 1989;143:2520-2524.
4. Leary AG, Ikebuchi K, Hirai Y, Wong GG, Yang YC, Clark SC, Ogawa M: Synergysm between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: Comparison with interleukin-l alpha. Blood 1988;71:1759-1763.
5. Gauldier J, Richards C, Harπish D, Lansdorp P, Baumann H: Interferon beta-2/B-ccll stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987;84:7251-7255.
6. Van Damme J, Cayphas S, Van Snick J, Con- ings R, Put W, Lenaerst JP: Purification and characterization of human fibroblast derived hybridoma growth factor identical to T-cell-de- rived B-cell stimulatory factor-2 (interleu- kin-6). Eur J Biochem 1987;168:543-550.
7. May LT, Ghraveb J, Santhanam V, Tatter SB, Sthoeger Z, Helfgott DC, Chiorazzi N, Grien- inger G, Segal PB: Synthesis and secretion of multiple forms of beta-2 interferon/B cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts anil monocytes. J Biol Chem 1989:263:7760-7766.
8. Shimizu S, Hirano T, Yoshioka K. Sugai S, Matsuda T, Taga T, Kishimoto T, Konda S: Interleukin 6(B-cell stimulatory factor 2)-depen- dent growth of a Lennert’s lymphoma-derived T ccll line (KT-3). Blood 1988;72:1826-1828.
9. Tovey MG, Content J, Grcsscr I, Gugenheim J, Blanchard B, Guymarho J, Poupart P, Gigou M, Shaw A, Fiers W: Genes for INF-beta 2, tumor necrosis factor, and IL-I are expressed at high levels in the organs of normal individuals. J Immunol 1988;141:3106-3110.
10. Kirnbauer R, Kock A, Schwarz T, Urbanski A, Krutmann J, Borth W, Damm D, Shipley G, Ansel JC, Luger TA: IFN-beta 2. B-cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines. J Immunol 1989;142:1922-1928.
11. Grossman RM, Krueger J, Yourish D, Gra- nelli-Piperno A, Murphy DP, May LT, Kupper TS, Segall PB, Gottlieb AB: Interleukin (› is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human kcratinocytes. Proc Natl Acad Sci USA 1989; 86:6367-6371.
12. Duncan MR, Berman B: Stimulation of collagen and glycositminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6, J Invest Dermatol 1991;97:686-692.
13. Castcll J, Klapproth J, Gross V, Walter E, An- dus T, Snyders L, Content J, Heinrich PC: Fate of interleukin-6 in the rat. Involvement of skin in its catabolism. Eur J Biochcm 1990;189:I13- 118.
14. Schindler R, Mancilla J Endres S, Ghorbani R, Clark SC, Dinarello CA: Correlation and interactions in the production of interleukin-6 (IL-6). IL-I and tumor necrosis factor (TNF) in human blood mononuclear cells. Blood 1990;75:40-47.
15. Hudson I, Hay FC: Affinity Techniques for Molecules and Cells in Practical Immunology. London, Blackwell, 1989.
16. Hsu SM, Raine L, Fanger H: Use of avidin-bio- tin-peroxidase complex (ABC) in immuno- pcroxidase technique: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochcm Cytochem 1981;29:577-580.
17. Hsu SM, Zhao X: Localization of interleukin-l in normal or reactive lymphatic tissue and skin: Abundance of IL-I in interdigitating reticulum cells. I.ymphokinc Res 1987;6:13-18.
18. Wolber RA, Lloyd RV: Cytomegalovirus detection by nonisotopic in situ DNA hybridization and viral antigen immunostaining using a two color technique. Hum Pathol 1988;19:736- 741.
19. Romero L, Ikejima T, Pincus SH: In situ localization of interleukin I in normal and psoriatic skin. J Invest Dermatol 1989;93:518-522.
20. F.isen AZ, Uitto J, Bauer EA: Scleroderma: in Fitzpatrick TB, Eisen AZ, Wolff K, Freeberg IM, Austen KF (eds): Dermatology in General Medicine, vol 3. New York. McGraw-Hill. 1987. pp 1841-1852.
21. Ohta Y, Katayama I, Funato T, Yokozeki H, Nishiyama S, Hirano T, Kishimoto T, Nishioka K: In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: Interleukin-6 involved in formation of psoriatic lesions. Arch Dermatol Res 1991;283:351-356.
22. Turksen K, Kupper TS, Degenstein L, Williams T, Fuchs E: IL-6: Insights to its function in skin by over expression in transgenic mice. Proc Natl Acad Sci USA 1992;89:5068-5072.
23. Kahaleh MB, DeLustro F, Bock W. LeRoy EC: Human monocyte modulation of endothelial cells and fibroblast growth: Possible mechanism for fibrosis. Clin Immunol Immunopathol 1986;39:242-255.
24. Ilayncs DC, Gershwin ME: The immunopa- thology of progressive systemic sclerosis (PSS). Semin Arthritis Rheum 1984;11:121-128.
25. Kahari V, Heino J, Vuorio E: Interleukin-1 increased collagen production and mRNA levels in cultured skin fibroblast. Biochim Biophys Acta 1987;929:142-147.
26. Alcocer-Varela J, Martincz-Cordero E, Alar- con-Segovia D: Spontaneous production of. and defective response to. intcrleukin-1 by peripheral blood mononuclear cells from patients with scleroderma. Clin Exp Immunol 1985;59: 666-672.
27. Wcstacott CL Whicher JT, Hutton CW, Dieppe PA: Increased spontaneous production of interleukin-1 together with inhibitory activity in systemic sclerosis. Clin Sci 1988;75:561-567.
28. Van Damme J, Van Snick J: Induction of hybridoma growth factor (HGF), identical to IL-6. in human fibroblasts by IL-1: Use of HGF activity in specific and sensitive biological assays for IL-1 and IL-6. Dev Biol Stand 1988;69:31-38.